Silvina Natalini Martinez

6PUBLICATIONS
27CO-AUTHORS
Adolescent healthAutonomic nervous systemDisease surveillancePreventative health carePredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 04, 2026
Immunogenicity and safety of co-administration of AS01E-adjuvanted respiratory syncytial virus prefusion F protein vaccine and a COVID-19 mRNA vaccine in adults aged ≥50 years: a phase 3, randomized, non-inferiority trial.

|Feb 25, 2025
Burden and Economic Impact of Respiratory Viral Infections in Adults Aged 60 and Older: A Focus on RSV.

Adrián Peláez, Sara Jimeno Ruiz, Mercedes Villarreal

|Nov 25, 2024
Impact of Respiratory Syncytial Virus (RSV) in Adults 60 Years and Older in Spain.

Sara Jimeno Ruiz, Adrián Peláez, Ángeles Calle Gómez

|Oct 26, 2024
Evaluating the Effectiveness of Nirsevimab in Reducing Pediatric RSV Hospitalizations in Spain.

Sara Jimeno Ruiz, Adrián Peláez, Agustín Labourt

|Aug 29, 2024
Omicron XBB.1.16-Adapted Vaccine for COVID-19: Interim Immunogenicity and Safety Clinical Trial Results.

María Jesús López Fernández, Silvia Narejos, Antoni Castro

|Apr 22, 2024
CROCuS, a Phase II Study Evaluating the Antiviral Activity, Clinical Outcomes, and Safety of Rilematovir in Children Aged ≥ 28 Days and ≤ 3 Years with Acute Respiratory Tract Infection Due to Respiratory Syncytial Virus.

Fernando Ferrero, Chien-Yu Lin, Johannes Liese

Pageof 1

Frequent Collaborators

3 joint publications

Sara Jimeno Ruiz

2 joint publications

Adrián Peláez

1 joint publications

Fernando Ferrero

1 joint publications

Chien-Yu Lin